Showing 1 - 5 results of 5 for search 'Derek Tang', query time: 0.03s Refine Results
  1. 1
    Opioid use and disposal patterns of emergency department patients

    Opioid use and disposal patterns of emergency department patients by Valerie Hoerster, Derek Tang, Marlee Milkis, Stephanie Litzenberger, Jill Stoltzfus, Holly Stankewicz

    Published 2023-01-01
    Get full text
    Article
  2. 2
    P1059: REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN MYELOFIBROSIS PATIENTS WITH ANEMIA

    P1059: REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN MYELOFIBROSIS PATIENTS WITH ANEMIA by John Mascarenhas, Krishnaveni Subbiah, Shalon Jones, Tao Gu, Derek Tang, Irene Degutis, Mrudula Glassberg

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Association between transfusion status and clinical and economic outcomes in patients with myelodysplastic syndromes from the physicians' perspective

    Association between transfusion status and clinical and economic outcomes in patients with myelodysplastic syndromes from the physicians' perspective by Shaloo Gupta, Austin G. Kulasekararaj, Halley Costantino, Jay Grisolano, Jackson Tang, Shalon Jones, Derek Tang

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA Trial

    Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Plac... by Ruben A. Mesa, Nicolaas Schaap, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srdan Verstovsek, Shelonitda Rose, Pranav Abraham, Jennifer Lord-Bessen, Derek Tang, Shien Guo, Xiaomei Ye, Claire N. Harrison

    Published 2021-05-01
    Get full text
    Article
  5. 5
    Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial

    Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes... by Claire N. Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Eric Jourdan, Richard T. Silver, Harry C. Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srdan Verstovsek, Derek Tang, Pranav Abraham, Jennifer Lord-Bessen, Shelonitda Rose, Shien Guo, Weiqin Liao, Ruben A. Mesa

    Published 2021-05-01
    Get full text
    Article

Search Tools: